title: Does magnesium therapy early in acute MI reduce mortality?
abstract: Short-term mortality is not reduced with early administration of intravenous magnesium in high-risk patients having an acute myocardial infarction (MI). There is no reason to give intravenous magnesium unless patients have other indications for repletion, such as a low magnesium level or arrhythmia responsive to magnesium therapy.
authors.affiliation: Virginia Commonwealth University, Fairfax Family Practice Residency, VA, USA.
authors.forename: John
authors.initials: J
authors.lastname: Phillips
authors.forename: Alex
authors.initials: A
authors.lastname: Krist
mesh_terms: D000368:Aged; D004311:Double-Blind Method; D019317:Evidence-Based Medicine; D006801:Humans; D007262:Infusions, Intravenous; D008278:Magnesium Sulfate / Q000008:administration & dosage*; D015337:Multicenter Studies as Topic; D009203:Myocardial Infarction / Q000188:drug therapy* / Q000401:mortality*; D017410:Practice Guidelines as Topic; D016032:Randomized Controlled Trials as Topic; D015996:Survival Rate; D013997:Time Factors; D016896:Treatment Outcome
chemical_list: D008278:Magnesium Sulfate